May 13, 2022 01:46 PM EDT
Pharma
Law

Is­rael sues Te­va over block­buster MS drug, seek­ing $100M in roy­al­ty pay — re­port

Paul Schloesser

Associate Editor

As Te­va is fac­ing opi­oid lit­i­ga­tion and po­ten­tial set­tle­ments in the US, it is now fac­ing more lit­i­ga­tion on the oth­er side of the world …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times